Whalegun
Home

Peter Blume-Jensen, President and CEO: Acrivon Therapeutics ACRV Buy · Filed 01/16

Trade details

Type
Insider buy
Amount
$82,320
Shares · price
49,000 sh · $1.68 a share
Held after
2,095,771 sh
Stock
Acrivon Therapeutics ACRV
Person
Peter Blume-JensenPresident and CEO
Trade date
26/01/14
Filed
26/01/16
Days to filing
2 days

First buy since 2023

Insiders buying this week
4 insiders
Holding change
+2.4%

Acrivon Therapeutics trades, last 26 weeks

What else happened in Acrivon Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/15~02/13

Peter Blume-Jensen's recent trades

  • Peter Blume-Jensen

    Planned saleAcrivon Therapeutics

    $30.6K

    Filed 08/25